Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Delsys to develop oral formulations of Parke-Davis drugs

May 4, 1998

Progenitor receives patent protection for stem cell technology

May 4, 1998

NeoRx receives SBIR grant for development of Pretarget technology

May 4, 1998

Improved gastrointestinal delivery of heparin with SNAC

May 1, 1998

Genetronics begins phase II trial of electroporation therapy in U.S.

May 1, 1998

CV Technologies reveals ChemBioPrint technology

April 29, 1998

Xoma licenses protein production technology to Invitrogen for research use

April 29, 1998

Abgenix, Genentech form research collaboration

April 29, 1998

Theratechnologies and Genetix enter strategic alliance

April 28, 1998

Genometrix and GeneMedicine embark on high-throughput screening effort

April 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...